日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial

每日两次服用固定剂量复方比克替拉韦-恩曲他滨-替诺福韦艾拉酚胺治疗利福平类结核病期间合并HIV感染(INSIGHT研究):一项2b期、开放标签、随机、非对照试验

Naidoo, Anushka; Naidoo, Kogieleum; Letsoalo, Marothi P; Wasmann, Roeland E; Dorse, Gillian; Perumal, Rubeshan; Moosa, Mahomed-Yunus S; Osuala, Emmanuella C; Boodhram, Resha; Chimukangara, Benjamin; Wiesner, Lubbe; Israelski, Dennis; Denti, Paolo; Rooney, James F; Dooley, Kelly E

High mortality among patients with tuberculosis accessing primary care facilities: secondary analysis from an open-label cluster-randomised trial

结核病患者在基层医疗机构就诊时死亡率高:一项开放标签整群随机试验的二次分析

Naidoo, Kogieleum; Zuma, Nonhlanhla Yende; Moodley, Mikaila; Made, Felix; Perumal, Rubeshan; Gengiah, Santhanalakshmi; Ngozo, Jacqueline; Padayatchi, Nesri; Nunn, Andrew; Karim, Salim Abdool

The gut and lung microbiome across the TB disease spectrum

结核病谱系中的肠道和肺部微生物组

Perumal, Rubeshan; Somboro, Anou M; Tulsi, Juhi; Ngcapu, Sinaye; Naidoo, Kogieleum

Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates

工程化分枝杆菌噬菌体TM4::GeNL可快速测定结核分枝杆菌临床分离株对贝达喹啉、普瑞托马尼、利奈唑胺、利福平和氯法齐明的敏感性

Rajagopalan, Saranathan; Rourke, Amy K; Asare, Emmanuel; Kohlerschmidt, Donna J; Das, Lahari; Ngema, Senamile L; Mulholland, Claire V; Vilchèze, Catherine; Mahalingam, Vaishnavi; Moodley, Sashen; Truebody, Barry; Mackenzie, Jared; Steyn, Adrie J C; Perumal, Rubeshan; Berney, Michael; Larsen, Michelle H; O'Donnell, Max R; Escuyer, Vincent E; Jacobs, William R Jr

Navigating Virology's Frontiers in Africa: Global Virus Network 2024 Durban Meeting

探索非洲病毒学前沿:2024年全球病毒网络德班会议

Bartlett, Maggie L; Perumal, Rubeshan; Vermund, Sten H; Abdool Karim, Salim

Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysis

基因组学在诊断贝达喹啉耐药结核病中的机遇与局限性:系统评价和个体分离株荟萃分析

Nimmo, Camus; Bionghi, Neda; Cummings, Matthew J; Perumal, Rubeshan; Hopson, Madeleine; Al Jubaer, Shamim; Naidoo, Kogieleum; Wolf, Allison; Mathema, Barun; Larsen, Michelle H; O'Donnell, Max

Are We Capable of Unveiling the Missed Epidemic of Isoniazid-resistant Tuberculosis?

我们能否揭露被忽视的异烟肼耐药结核病疫情?

Perumal, Rubeshan; Naidoo, Kogieleum

Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB

全口服耐药结核病(DR-TB)治疗方案的快速分诊检测:一项评估Xpert MTB/XDR检测在DR-TB快速分诊和治疗中的有效性、可行性、可接受性和成本效益的IV期研究

Naidoo, Kogieleum; Naidoo, Anushka; Abimiku, Alash'le G; Tiemersma, Everdina W; Gebhard, Agnes; Hermans, Sabine M; Sloan, Derek J; Ruhwald, Morten; Georghiou, Sophia B; Okpokoro, Evaezi; Agbaje, Aderonke; Yae, Kalkidan; Tollera, Getachew; Moga, Shewki; Feyt, Hannelise; Kachoka, Takondwa; Letsoalo, Marothi P; Cabibbe, Andrea M; Perumal, Rubeshan; Shunmugam, Letitia; Cirillo, Daniela M; Foraida, Salah; Sabiiti, Wilber; Ntinginya, Nyanda Elias; Mtafya, Bariki; Bedru, Ahmed; Gillespie, Stephen H

Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infection

针对多重耐药结核病合并艾滋病毒感染者的差异化服务提供框架

Reis, Karl; Wolf, Allison; Perumal, Rubeshan; Seepamore, Boitumelo; Guzman, Kevin; Ross, Jesse; Cheung, Ken; Amico, K Rivet; Brust, James C M; Padayatchi, Nesri; Friedland, Gerald; Naidoo, Kogieleum; Daftary, Amrita; Zelnick, Jennifer; O'Donnell, Max

Advances in tuberculosis control during the past decade

过去十年结核病控制方面的进展

Naidoo, Kogieleum; Perumal, Rubeshan